Medrx: Confirmatory letter.
Medrx: Announcement of differences between financial estimates and actual results for the second quarter (interim period) of the fiscal year ending December 2024.
Medrx: Announcement of revised financial estimates.
Medrx: Financial statement for the second quarter (interim period) of the fiscal year ending December 2024 [Japan standards] (consolidated).
Medrx: Semi-annual report - 23rd period (2024/01/01 - 2024/12/31)
Medrx: Announcement of revised financial estimates.
MEDRX: Extraordinary Report
MEDRX: Confirmation letter
MEDRX: Quarterly Report - 23rd Quarter 1 (2024/01/01 to 2024/03/31)
MEDRX: Notice regarding revisions to earnings forecasts
MEDRX: Summary of Financial Results for the 1st Quarter Ending 2024/12 [Japanese GAAP] (Consolidated)
MEDRX: Notice regarding revisions to earnings forecasts
MEDRX: Extraordinary Report
MEDRX: Confirmation letter
MEDRX: Financial Report - 22nd Term (2023/01/01 - 2023/12/31)
Medrex: (Correction) Partial Corrections to “Financial Results Presentation Materials for the Fiscal Year Ending December 2023”
Medrex: Financial results briefing materials for the fiscal year ending 2023/12
Medrx: Summary of Financial Results for the Fiscal Year Ending 2023/12 [Japanese GAAP] (Consolidated)
Medrx: Confirmation letter
Medrx: Quarterly Report - 22nd Third Quarter (2023/07/01 - 2023/09/30)
No Data